San Francisco 25 April 2019 The Report In-Vitro Fertilization (IVF) Market Size, Share & Trends Analysis Report By
Type, By Instrument (Disposable Devices, Culture Media, Capital Equipment), By
End Use, By Region, And Segment Forecasts, 2019 - 2026
The global in-vitro fertilization market size is expected to reach USD 36.2 billion by 2026, based
on a new report by Grand View Research, Inc. It is projected to expand at a
CAGR of 10.2% during the forecast period. The market is driven by the
increasing incidence of infertility owing to lifestyle changes, government
initiatives to provide better reimbursement policies, and the continuous
efforts by the industry contributors. Expansion of fertility procedures for
treating male infertility such as ICSI, is projected to positively influence
the growth in near future.
Moreover, availability of genomic testing
with the ability to prevent the transfer of genetic disease during IVF
procedure is expected to drive the market. Increasing number of IVF treatments
has encouraged more insurance providers to cover these procedures. This has
ultimately led to competitive pricing and has moderated the treatment costs,
driving the market with more treatment standardization and automation.
The behavioral shift in the society is the
major factor contributing to the decreased Total Fertility Rate (TFR). This
shift reflects on increasing number of working women, advanced maternal age, a
shift from rural to urban societies, lower marriage rates, and delaying
marriages. Such factors are projected to drive the in-vitro fertilization
market during the forecast period.
Obesity is another factor leading to an
increase in infertility. The fat deposited on women’s abdomen prevents
follicular stimulation and produces male hormones. In case of males, rising fat
deposits decrease testosterone levels and can result in lowered sperm production.
Doctors recommend weight loss in men prior to fertility treatments along with
proper maintenance of Body Mass Index (BMI). The U.S. Endocrine Society has
established the use of Letrozole to increase the testosterone levels in obese
patients.
The presence of favorable reimbursement
framework, such as implementation of USD 50 million 5-year plans by the U.S
Department of Defense for sperm/egg freezing coverage, is expected to drive the
regional growth over the next six years. Increasing number of clinics
undertaking newer techniques to offer better fertility success rates is also
expected to boost the regional demand.
In Europe, the NHS covers three IVF cycles
and provides coverage for gametes freezing. Moreover, the region is an
attraction for international clients as countries, as countries such as Spain,
have the highest number of egg donors. The clinics also provide sex
identification and other IVF treatments, which are not offered in North
America.
The Asia Pacific Initiative on Reproduction
(ASPIRE) consists of a task force of clinicians and scientists involved in
monitoring and managing fertility and Assisted Reproductive Technology (ART).
Such initiatives promote awareness levels among consumers thereby, driving the
growth of the IVF market.
Industry contributors are introducing
advanced automation to shift the IVF treatment from invasive to minimally
invasive or non-invasive procedure. The industry players are also working on
technologies, which can enable older women to have enhanced fertility rates. In
August 2015, OvaScience announced the results of its first published analysis
comparing AUGMENT fertility treatment with a standard IVF. The results showed a
significantly higher rate of selection and transfer of embryos as compared to
the standard treatment.
Access Research Report of IVF Market@ https://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market
Further key findings from the study suggest:
· Culture media led the overall market in
terms of revenue in 2018. With the increasing government funding and industrial
support for employees for egg/sperm freezing, the demand for cryopreservation
and the required media for it, is expected to witness growth
· Increasing number of egg/sperm donor banks
is expected to drive the demand for sperm, egg, and embryo processing media
during the forecast period
· Fresh non-donor segment led the market in
2018. According to the 2003 - 2012 trends by the CDC, the number of fresh
non-donors banking the eggs/embryos has drastically increased in U.S
· Europe led the in-vitro fertilization
procedure and instrument market in 2018. High quality of treatment at
economical prices and the adherence to medical standards have contributed to
its market leadership
· North America also accounted for a
significant market share in 2018. The standardization of procedures through
automation, regulatory reforms, government funding for egg/sperm storage, and
industry players introducing more IVF treatments are some contributing factors
for the regional growth
· The demand for IVF treatment is expected to
boom in APAC owing to fertility tourism and increasing penetration and
awareness regarding the treatment in the developing economies
· Some key players in the In-vitro Fertilization
(IVF) market include EMD Serono Inc.; Boston IVF; OvaScience; Thermo Fisher
Scientific Inc.; Vitrolife AB; Irvine Scientific; CooperSurgical, Inc.; Cook
Medical Inc.; Genea Biomedx; and Progyny Inc.
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the global In-Vitro Fertilization (IVF) market by type, instrument,
end use, and region:
In-Vitro Fertilization (IVF) Instrument
Outlook (Revenue, USD Million, 2015 - 2026)
·
Disposable Devices
·
Culture Media
·
Capital Equipment
In-Vitro Fertilization (IVF) Type Outlook
(Revenue, USD Million, 2015 - 2026)
·
Fresh Non-donor
·
Frozen Non-donor
·
Fresh Donor
·
Frozen Donor
In-Vitro Fertilization (IVF) End Use
Outlook (Revenue, USD Million, 2015 - 2026)
·
Hospitals & others
·
Fertility Clinics
In-Vitro Fertilization (IVF) Regional
Outlook (Revenue, USD Million, 2015 - 2026)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East and Africa
Access Press Release of
IVF Market@ https://www.grandviewresearch.com/press-release/global-ivf-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
No comments:
Post a Comment